Amin S Herati1,2, Taylor P Kohn2, Peter R Butler1,2, Larry I Lipshultz1,2. 1. Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030. 2. Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030.
Abstract
PURPOSE OF THE REVIEW: This review summarizes the current literature regarding the effects of testosterone therapy (TTh) on common disorders of the prostate. RECENT FINDINGS: Testosterone therapy has gained credibility over the last several decades as a potentially safe co-treatment modality for men with benign and malignant prostatic conditions. Our understanding of the effects of testosterone on the prostate continues to evolve with ongoing clinical and basic science research. Findings of these studies have reinvigorated the debate over the effects of testosterone on benign and malignant disorders of the prostate, including BPH, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and prostate cancer. SUMMARY: Despite the burgeoning body of data claiming the safety and efficacy of TTh in common prostatic conditions (including BPH, CP/CPPS, and prostate cancer), diligent monitoring, appropriate patient selection, and informed consent are critical until more definitive studies are performed.
PURPOSE OF THE REVIEW: This review summarizes the current literature regarding the effects of testosterone therapy (TTh) on common disorders of the prostate. RECENT FINDINGS:Testosterone therapy has gained credibility over the last several decades as a potentially safe co-treatment modality for men with benign and malignant prostatic conditions. Our understanding of the effects of testosterone on the prostate continues to evolve with ongoing clinical and basic science research. Findings of these studies have reinvigorated the debate over the effects of testosterone on benign and malignant disorders of the prostate, including BPH, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and prostate cancer. SUMMARY: Despite the burgeoning body of data claiming the safety and efficacy of TTh in common prostatic conditions (including BPH, CP/CPPS, and prostate cancer), diligent monitoring, appropriate patient selection, and informed consent are critical until more definitive studies are performed.
Authors: Anne M Kenny; Alison Kleppinger; Kristen Annis; Margaret Rathier; Bruce Browner; James O Judge; Daniel McGee Journal: J Am Geriatr Soc Date: 2010-06 Impact factor: 5.562
Authors: Eduard García-Cruz; Marta Piqueras; Maria José Ribal; Jorge Huguet; Rodrigo Serapiao; Lluis Peri; Laura Izquierdo; Antonio Alcaraz Journal: BJU Int Date: 2012-01-18 Impact factor: 5.588
Authors: Brian R Lane; Andrew J Stephenson; Cristina Magi-Galluzzi; Milton M Lakin; Eric A Klein Journal: Urology Date: 2008-08-09 Impact factor: 2.649
Authors: Eduardo García-Cruz; Marta Piqueras; Jorge Huguet; Lluis Peri; Laura Izquierdo; Mireia Musquera; Agustin Franco; Ricardo Alvarez-Vijande; Maria Jose Ribal; Antonio Alcaraz Journal: BJU Int Date: 2012-05-15 Impact factor: 5.588